Abstract
BackgroundFor decades, high-dose intravenous cyclophosphamide (ivCY) given for 24-30 months was regarded standard therapy for systemic lupus erythematosus (SLE) patients with proliferative lupus nephritis (LN). Previously, we showed that induction...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have